The stock has hit the upper limit. It was announced that a visit to the Pharmaceuticals and Medical Devices Agency (PMDA) took place on the 18th, during which some of the clinical-related application documents were submitted, and additional questions were received from the PMDA. It is planned to submit responses to those questions and additional clinical-related application documents between the end of November and the beginning of December. Quallus revealed in June that it would submit an application for approval of iPS cell-derived cardiac cell sheets for ischemic cardiomyopathy within the year, seemingly attracting investor speculation related to this visit.
クオリプス---ストップ高、PMDAに臨床関連申請資料の一部提出、承認申請で思惑
Qualips --- Hit the ceiling price, submitted part of clinical-related application materials to PMDA, speculation on approval application.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated